MM-1037: Elranatamab (ELRA) in Combination With Daratumumab and Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma (NDMM) Not Eligible for Transplant: Initial Results From MagnetisMM-6 Part 1 | Publicación